Other
COVID-19
Jan. 8, 2021
- Staff Statement Regarding Rule 302(b) of Regulation S-T in Light of COVID-19 Concerns (11/20/20)
- Commission extends effective period for Regulation Crowdfunding relief to facilitate capital formation for small businesses impacted by coronavirus disease 2019 (COVID-19) (8/28/2020)
- Division of Corporation Finance Statement Regarding Submission of Supplemental Materials and Information Subject to Rule 83 Confidential Treatment Requests in Light of COVID-19 Concerns (8/4/2020)
- Division of Corporation Finance Statement Regarding Requirements for Form 144 Paper Filings in Light of COVID-19 Concerns (6/25/2020)
- Division of Corporation Finance Statement Regarding Requirements for Certain Paper Documents (other than Forms 144) in Light of COVID-19 Concerns (6/25/2020)
- CF Disclosure Guidance Topic: COVID-19 Disclosure Considerations Regarding Operations, Liquidity, and Capital Resources (6/23/20)
- COVID-19 Related FAQs (5/4/2020)
- Staff Guidance for Conducting Shareholder Meetings in Light of COVID-19 Concerns (4/7/2020)
- Staff Interpretations Regarding Certain Exchange Act Forms (Form 10-K, Part III; Form 40-F) (4/6/2020)
- Staff Interpretations Regarding Rule 12b-25 (3/31/2020)
- Relief for Form ID Filers and Regulation Crowdfunding and Regulation A Issuers Related to COVID-19 (3/26/2020)
- Extension of Conditional Regulatory Relief from Reporting and Proxy Delivery Requirements for Public Companies (3/25/2020)
- CF Disclosure Guidance Topic: Coronavirus (COVID-19) (3/25/2020)
- Conditional Regulatory Relief and Assistance for Companies Affected by COVID-19 (3/4/2020)
- Statement on Continued Dialogue with Audit Firm Representatives on Audit Quality in China and Other Emerging Markets; Coronavirus — Reporting Considerations and Potential Relief (2/19/2020)
Modified: Jan. 8, 2021